Skip to main content

House Publications

The Debates are the report—transcribed, edited, and corrected—of what is said in the House. The Journals are the official record of the decisions and other transactions of the House. The Order Paper and Notice Paper contains the listing of all items that may be brought forward on a particular sitting day, and notices for upcoming items.

For an advanced search, use Publication Search tool.

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

Previous day publication Next day publication

Notice Paper

No. 78

Monday, April 14, 2008

11:00 a.m.


Introduction of Government Bills

April 11, 2008 — The Minister of Justice — Bill entitled “An Act to amend the Criminal Code (auto theft and trafficking in property obtained by crime)”.

Introduction of Private Members' Bills

Notices of Motions (Routine Proceedings)

Questions

Notices of Motions for the Production of Papers

Business of Supply

Government Business

Private Members' Notices of Motions

M-483 — April 11, 2008 — Mr. Vellacott (Saskatoon—Wanuskewin) — That, in the opinion of the House, the government should propose amendments to the Divorce Act so that law and practice ensure due process protection of rights and equality of parents, and to ensure that children benefit from equal parenting from both their mother and their father, after separation or divorce.

Private Members' Business

M-426 — December 6, 2007 — Mr. Bell (North Vancouver) — That, in the opinion of the House, the government should respond specifically to the challenges faced by Canadians with rare diseases and disorders, and the initiative put forward by the Canadian Organization for Rare Disorders by: (a) establishing the definition for serious rare disorders as those with a prevalence of less than 1 in 2000 Canadians; (b) examining the feasibility of a national “Chance for Life Fund” equivalent to 2% of the total annual public drug expenditure to be designated for therapies for rare disorders; (c) considering the establishment of a multi-stakeholder advisory body, including treaters and patients, to recommend treatment access for life-threatening or serious rare disorders, based on scientific standards and social values; (d) considering the establishment of centres of reference for specific rare disorders, comprised of national and international experts, who will develop criteria for treating patients based on scientific evidence and patient impact and provide on-going surveillance into the real-world safety and effectiveness of these treatments on individual and group basis; (e) considering options to provide incentives through orphan drug regulation and policy, to assure Canadian organizations and researchers are motivated to conduct research and development into treatments for rare and neglected disorders; (f) supporting internationally accepted standards for conduct of clinical trials in rare disorders appropriate for the challenges inherent to very small patient populations; (g) considering ensuring that Health Canada’s progressive licensing framework provide appropriate support to the design of clinical trials for very small patient populations and appropriate review of evidence submitted from these trials; and (h) reporting the progress accomplished to the House within six months.